EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase

Riham Rafea, Mauro Siragusa, Ingrid Fleming iD

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70029 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Riham Rafea und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type III, Nitric Oxide. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitric oxide (NO) generated by the endothelial NO synthase (eNOS) plays an essential role in the maintenance of vascular homeostasis and the prevention of vascular inflammation. There are a myriad of mechanisms that regulate the activity of the enzyme that may prove to represent interesting therapeutic opportunities. In this regard, the kinases that phosphorylate the enzyme and regulate its activity in situations linked to vascular disease seem to be particularly promising. Although the actions of NO were initially linked mainly to the activation of the guanylyl cyclase and the generation of cyclic GMP in vascular smooth muscle cells and platelets, it is now clear that NO elicits the majority of its actions via its ability to modify redox‐activated cysteine residues in a process referred to as S ‐nitrosylation. The more wide spread use of mass spectrometry to detect S ‐nitrosylated proteins has helped to identify just how large the NO sphere of influence is and just how many cellular processes are affected. It may be an old target, but the sheer impact of eNOS on vascular health really justifies a revaluation of therapeutic options to maintain and protect its activity in situations associated with a high risk of developing cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide Synthase Type IIINitric OxideHumansAnimalsCardiovascular DiseasesMuscle, Smooth, VascularOxidation-ReductionPhosphorylationCyclic GMPEndothelium, Vascular

Stichwörter der Autor:innen

RNA editingS‐nitrosylationeNOSeNOS phosphorylationmetabolism

Substanzen

Nitric Oxide Synthase Type IIINitric OxideCyclic GMP

Autor:innen und Institutionen

  • Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany.
  • Partner Site RheinMain, German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany.

ORCID-Profile: Ingrid Fleming

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Rafea, R., Siragusa, M., & Fleming, I. (2025). The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70029

Vancouver

Rafea R, Siragusa M, Fleming I. The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70029

BibTeX
@article{Rafea2025,
  author = {Rafea, Riham and Siragusa, Mauro and Fleming, Ingrid},
  title = {The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70029}
}
Kostenlos starten →